Regulatory mechanisms for transforming growth factor β as an autocrine inhibitor in human hepatocellular carcinoma: Implications for roles of smads in its growth

Hepatology

Volumn 32, Issue 2, 2000, Pages 218-227

  Matsuzaki, Koichi ^a   Date, Masataka ^a   Furukawa, Fukiko ^a   Tahashi, Yoshiya ^a   Matsushita, Masanori ^a   Sugano, Yasushi ^a   Yamashiki, Noriyo ^a   Nakagawa, Taichi ^a   Seki, Toshihito ^a   Nishizawa, Mikio ^a   Fujisawa, Junichi ^a   Inoue, Kyoichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE INDUCTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0033865273     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.9145     Document Type: Article

References (46)

1. Peptide growth factors and their receptors
2. TGF-β signal transduction
3. Mechanism of activation of the TGF-β receptor
4. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling
5. Receptor-associated Mad homologues synergize as effectors of the TGF- β response
6. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways
7. Smads: Transcriptional activators of TGF-β responses
8. Regulation of Smad activity
9. Smad 6 inhibits signalling by the TGF-β superfamily
10. Smad 6 inhibits BMP/Smad 1 signaling by specifically competing with the Smad 4 tumor suppressor
11. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
12. Identification of Smad 7, a TGF-β-inducible antagonist of TGF-β signalling
13. Regulation of Smad 7 promoter by direct association with Smad 3 and Smad 4
14. Role of growth factors and cytokines in hepatic regeneration
15. Transforming growth factor-beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers
16. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma
17. Autocrine stimulatory mechanism by transforming growth factor-β in human hepatocellular carcinoma
18. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells
19. Differential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration
20. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: Invalidity of the antibodies for tumor angiogenesis
21. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein β and nuclear factor-κB in hepatocytes
22. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
23. Down-regulation of TGF-β receptors in human colorectal cancer: Implications for cancer development
24. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex
25. TGF-β signals through a heteromeric protein kinase receptor complex
26. Growth stimulation of human breast cancer cells with anti-transforming growth factor antibodies: Evidence for negative autocrine regulation by transforming growth factor
27. 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation
28. 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector
29. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12
30. SARA, a FYVE domain protein that recruits Smad 2 to the TGFβ receptor
31. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
32. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanisms
33. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad 3
34. Interaction of the Ski oncoprotein with Smad 3 regulates TGF-β signaling
35. Transforming growth factor b and cell cycle regulation
36. 1 arrest pathway
37. Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-α in transgenic mice is associated with TGF-β1 signaling disruption
38. Expression of Smad proteins in human colorectal cancer
39. Increased Smad expression and activation are associated with apoptosis in normal and malignant prostate after castration
40. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital
41. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma
42. Mutation analysis of the transforming growth factor β type II receptor in sporadic human cancers of the pancreas, liver, and breast
43. Microsatellite instability in European hepatocellular carcinoma
44. Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma
45. DPC4 gene in various tumor types
46. Smad 2 and Smad 4 gene mutations in hepatocellular carcinoma